New wound scanner aims to spot hidden bacteria

NCT ID NCT07611318

ENROLLING_BY_INVITATION Diagnosis Sponsor: Capsicure, LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new device, cureVision cV, to an existing one (MolecuLight i:X) to see if it can accurately detect moderate to high levels of bacteria in wounds. About 100 adults with various wound types (like diabetic foot ulcers or surgical wounds) will be enrolled. The goal is to show the new device works just as well, so it can be sold in the US.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DFU are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

decubitus ulcer dengue disease injury Surgical Wound ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DFU PRESSURE INJURIES SURGICAL WOUND VLU WOUNDS

Contacts and locations

Locations

Halo Clinical Research

Houston, Texas, 77035, United States
NAR Medical Research Group

Miami, Florida, 33135, United States
NOVA Medical Research

Miami, Florida, 33176, United States
North Park Podiatry, Foot and Ankle Surgery

San Diego, California, 92104, United States
Solutions Medical Research

Coral Gables, Florida, 33134, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.